SIM
KMTS

Sandia Investment Management’s Kestra Medical Technologies KMTS Stock Holding History

Sandia Investment Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$17.3K Buy
+653
New +$16.8K 0.04% 116

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Sandia Investment Management's KMTS Position: Q4 2025 in Review

Sandia Investment Management opened a new position in Kestra Medical Technologies (KMTS) in Q4 2025: 653 shares worth $17.3K. The stake represents 0.04% of the portfolio and ranks #116 among its holdings.

107 funds tracked by Wall St. Rank hold KMTS as of Q4 2025.

  • Sandia Investment Management held 653 shares of Kestra Medical Technologies worth $17.3K as of Q4 2025.
  • Kestra Medical Technologies was a new Sandia Investment Management position in Q4 2025.
  • Kestra Medical Technologies made up 0.04% of Sandia Investment Management's portfolio in Q4 2025, its #116 holding.
  • 107 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q4 2025.

Based on Sandia Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.